Role of macrophage migration inhibitory factor in the Th2 immune response to epicutaneous sensitization

R Das, JE Moss, E Robinson, S Roberts, R Levy… - Journal of clinical …, 2011 - Springer
R Das, JE Moss, E Robinson, S Roberts, R Levy, Y Mizue, L Leng, C McDonald, RE Tigelaar…
Journal of clinical immunology, 2011Springer
We examined the role of macrophage migration inhibitory factor (MIF) in the generation of
the Th2 response using MIF-deficient mice in a model of epicutaneous sensitization to
ovalbumin. Lymph node cells from sensitized MIF-deficient mice produce lower levels of Th2
cytokines after antigen challenge when compared to their wild-type counterparts. Sensitized
mice lacking MIF show less pulmonary inflammation after intranasal antigen exposure. Mice
deficient in CD74, the MIF receptor, also are unable to generate an inflammatory response …
Abstract
We examined the role of macrophage migration inhibitory factor (MIF) in the generation of the Th2 response using MIF-deficient mice in a model of epicutaneous sensitization to ovalbumin. Lymph node cells from sensitized MIF-deficient mice produce lower levels of Th2 cytokines after antigen challenge when compared to their wild-type counterparts. Sensitized mice lacking MIF show less pulmonary inflammation after intranasal antigen exposure. Mice deficient in CD74, the MIF receptor, also are unable to generate an inflammatory response to epicutaneous sensitization. Examination of the elicitation phase of the atopic response using DO11.10 OVA TCR transgenic animals shows that T cell proliferation and IL-2 production are strongly impaired in MIF-deficient T cells. This defect is most profound when both T cells and antigen-presenting cells are lacking MIF. These data suggest that MIF is crucial both for the sensitization and the elicitation phases of a Th2-type immune response in allergic disease.
Springer